Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker PCRX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Lauren Riker Officer | PCRX Pacira BioSciences, Inc. | 6,000 | $217.9K | 10b5-1 | Oct 8, 2026 | — | Form 144 ↗ |
| Aug 17, 2026 | Jonathan Slonin Officer | PCRX Pacira BioSciences, Inc. | 3,040 | $70.6K | 10b5-1 | Aug 17, 2026 | Form 4 ↗ 1 day later · 3,040 shares | Form 144 ↗ |
| Jun 12, 2026 | Ceesay Abraham Director | PCRX Pacira BioSciences, Inc. | 9,039 | $210.4K | — | Jun 12, 2026 | — | Form 144 ↗ |
| Jun 11, 2026 | Lauren Riker Officer | PCRX Pacira BioSciences, Inc. | 6,115 | $143.7K | 10b5-1 | Jun 11, 2026 | Form 4 ↗ 1 day later · 6,115 shares | Form 144 ↗ |
| Jun 4, 2026 | Kristen Williams Officer | PCRX Pacira BioSciences, Inc. | 10,259 | $228.5K | 10b5-1 | Jun 4, 2026 | Form 4 ↗ 1 day later · 10,259 shares | Form 144 ↗ |
| Apr 23, 2026 | Shawn Cross Officer | PCRX Pacira BioSciences, Inc. | 12,941 | $325.6K | 10b5-1 | Apr 23, 2026 | Form 4 ↗ 1 day later · 12,941 shares | Form 144 ↗ |
| Apr 22, 2026 | Shawn Cross Officer | PCRX Pacira BioSciences, Inc. | 1,500 | $37.5K | 10b5-1 | Apr 22, 2026 | Form 4 ↗ same day · 12,059 shares | Form 144 ↗ |
| Apr 21, 2026 | Shawn Cross Officer | PCRX Pacira BioSciences, Inc. | 2,845 | $71.1K | 10b5-1 | Apr 21, 2026 | Form 4 ↗ 1 day later · 12,059 shares | Form 144 ↗ |
| Apr 20, 2026 | Shawn Cross Officer | PCRX Pacira BioSciences, Inc. | 7,714 | $193.9K | 10b5-1 | Apr 20, 2026 | Form 4 ↗ 2 days later · 12,059 shares | Form 144 ↗ |
| Mar 17, 2026 | Mark Froimson Director | PCRX Pacira BioSciences, Inc. | 500 | $10.9K | — | Mar 17, 2026 | Form 4 ↗ 2 days later · 500 shares | Form 144 ↗ |
| Mar 17, 2026 | Jonathan Slonin Officer | PCRX Pacira BioSciences, Inc. | 3,261 | $74.4K | 10b5-1 | Mar 17, 2026 | Form 4 ↗ 2 days later · 3,261 shares | Form 144 ↗ |
| Feb 2, 2026 | Lauren Riker Officer | PCRX Pacira BioSciences, Inc. | 4,000 | $84.2K | 10b5-1 | Feb 2, 2026 | Form 4 ↗ 1 day later · 4,000 shares | Form 144 ↗ |
| Feb 2, 2026 | Kristen Williams Officer | PCRX Pacira BioSciences, Inc. | 13,137 | $269.7K | 10b5-1 | Feb 2, 2026 | Form 4 ↗ 1 day later · 13,137 shares | Form 144 ↗ |
| Jan 5, 2026 | Lauren Riker Officer | PCRX Pacira BioSciences, Inc. | 1,416 | $34.3K | 10b5-1 | Jan 5, 2026 | Form 4 ↗ 1 day later · 1,416 shares | Form 144 ↗ |
| Dec 10, 2025 | Shawn Cross Officer | PCRX Pacira BioSciences, Inc. | 9,104 | $228.9K | 10b5-1 | Dec 10, 2025 | Form 4 ↗ 1 day later · 25,000 shares | Form 144 ↗ |
| Dec 9, 2025 | Shawn Cross Officer | PCRX Pacira BioSciences, Inc. | 15,896 | $397.8K | 10b5-1 | Dec 9, 2025 | Form 4 ↗ 2 days later · 25,000 shares | Form 144 ↗ |
| Nov 17, 2025 | Jonathan Slonin Officer | PCRX Pacira BioSciences, Inc. | 3,960 | $95.4K | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 2 days later · 3,960 shares | Form 144 ↗ |
| Nov 10, 2025 | Shawn Cross Officer | PCRX Pacira BioSciences, Inc. | 12,060 | $266.4K | 10b5-1 | Nov 10, 2025 | Form 4 ↗ 3 days later · 12,060 shares | Form 144 ↗ |
| Sep 4, 2025 | Ceesay Abraham Director | PCRX Pacira BioSciences, Inc. | 2,354 | $64.0K | 10b5-1 | Sep 4, 2025 | Form 4 ↗ 4 days later · 2,354 shares | Form 144 ↗ |
| Aug 7, 2025 | Bigal Marcelo Director | PCRX Pacira BioSciences, Inc. | 4,912 | $116.3K | — | Aug 7, 2025 | Form 4 ↗ 4 days later · 4,912 shares | Form 144 ↗ |
| Jun 4, 2025 | Lauren Riker Officer | PCRX Pacira BioSciences, Inc. | 5,579 | $146.2K | — | Jun 4, 2025 | Form 4 ↗ 1 day later · 5,578 shares | Form 144 ↗ |
| Jun 4, 2025 | Kristen Williams Officer | PCRX Pacira BioSciences, Inc. | 14,376 | $377.2K | — | Jun 4, 2025 | Form 4 ↗ 1 day later · 14,376 shares | Form 144 ↗ |
| Mar 6, 2025 | Daryl Gaugler Officer | PCRX Pacira BioSciences, Inc. | 500 | $11.6K | 10b5-1 | Mar 6, 2025 | — | Form 144 ↗ |
| Jan 6, 2025 | Jonathan Slonin Officer | PCRX Pacira BioSciences, Inc. | 879 | $16.2K | 10b5-1 | Jan 6, 2025 | Form 4 ↗ same day · 879 shares | Form 144 ↗ |
| Dec 13, 2024 | Daryl Gaugler Officer | PCRX Pacira BioSciences, Inc. | 500 | $9,880 | 10b5-1 | Dec 13, 2024 | Form 4 ↗ 3 days later · 500 shares | Form 144 ↗ |
| Sep 13, 2024 | Daryl Gaugler Officer | PCRX Pacira BioSciences, Inc. | 500 | $6,430 | 10b5-1 | Sep 13, 2024 | — | Form 144 ↗ |
| Aug 2, 2024 | Jonathan Slonin Officer | PCRX Pacira BioSciences, Inc. | 945 | $18.9K | 10b5-1 | Aug 2, 2024 | — | Form 144 ↗ |
| Jul 2, 2024 | Jonathan Slonin Officer | PCRX Pacira BioSciences, Inc. | 2,836 | $80.1K | 10b5-1 | Jul 2, 2024 | — | Form 144 ↗ |
| Jun 13, 2024 | Daryl Gaugler Officer | PCRX Pacira BioSciences, Inc. | 1,000 | $28.4K | 10b5-1 | Jun 13, 2024 | — | Form 144 ↗ |
| Jun 13, 2024 | Kristen Williams Officer | PCRX Pacira BioSciences, Inc. | 7,452 | $211.5K | 10b5-1 | Jun 13, 2024 | — | Form 144 ↗ |
| Jun 13, 2024 | Paul J. Hastings Director | PCRX Pacira BioSciences, Inc. | 880 | $25.0K | 10b5-1 | Jun 13, 2024 | — | Form 144 ↗ |
| Jun 12, 2024 | Lauren Riker Officer | PCRX Pacira BioSciences, Inc. | 3,970 | $114.0K | 10b5-1 | Jun 12, 2024 | — | Form 144 ↗ |
| Jun 11, 2024 | Jonathan Slonin Officer | PCRX Pacira BioSciences, Inc. | 5,012 | $143.2K | 10b5-1 | Jun 11, 2024 | — | Form 144 ↗ |
| Mar 6, 2024 | Gary W. Pace Board member | PCRX Pacira BioSciences, Inc. | 120,483 | $3.6M | — | Mar 6, 2024 | — | Form 144 ↗ |
| Nov 13, 2023 | Winston Roy Former Officer | PCRX Pacira BioSciences, Inc. | 31,000 | $875.9K | — | Nov 10, 2023 | — | Form 144 ↗ |
| Aug 2, 2023 | Winston Roy Officer | PCRX Pacira BioSciences, Inc. | 509 | $17.8K | — | Aug 2, 2023 | — | Form 144 ↗ |
| Jul 5, 2023 | Riker Lauren Bullaro Officer | PCRX Pacira BioSciences, Inc. | 643 | $25.7K | 10b5-1 | Jul 5, 2023 | — | Form 144 ↗ |
| Jun 14, 2023 | Riker Lauren Bullaro Officer | PCRX Pacira BioSciences, Inc. | 6,366 | $244.6K | 10b5-1 | Jun 14, 2023 | — | Form 144 ↗ |
| Jun 14, 2023 | Kristen Marie Williams Officer | PCRX Pacira BioSciences, Inc. | 6,467 | $239.5K | 10b5-1 | Jun 14, 2023 | — | Form 144 ↗ |
| Jun 12, 2023 | Max Reinhardt Officer | PCRX Pacira BioSciences, Inc. | 5,085 | $183.2K | 10b5-1 | Jun 12, 2023 | — | Form 144 ↗ |
| Jun 8, 2023 | Mark A. Kronenfeld Director | PCRX Pacira BioSciences, Inc. | 15,000 | $560.7K | 10b5-1 | Jun 8, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Daryl Gaugler Officer | PCRX Pacira BioSciences, Inc. | 1,047 | $39.6K | — | Jun 7, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Riker Lauren Bullaro Officer | PCRX Pacira BioSciences, Inc. | 616 | $23.3K | — | Jun 7, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Jonathan Slonin Officer | PCRX Pacira BioSciences, Inc. | 490 | $18.6K | — | Jun 7, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Charles A. Reinhart III Officer | PCRX Pacira BioSciences, Inc. | 1,371 | $51.9K | — | Jun 7, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Dennis McLoughlin Officer | PCRX Pacira BioSciences, Inc. | 1,057 | $40.0K | — | Jun 7, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Ronald J. Ellis Jr. Officer | PCRX Pacira BioSciences, Inc. | 1,162 | $44.0K | — | Jun 7, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | David M. Stack Officer, Director | PCRX Pacira BioSciences, Inc. | 5,326 | $201.7K | — | Jun 7, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Kristen Marie Williams Officer | PCRX Pacira BioSciences, Inc. | 1,357 | $51.4K | — | Jun 7, 2023 | — | Form 144 ↗ |
| Jun 7, 2023 | Max Reinhardt Officer | PCRX Pacira BioSciences, Inc. | 1,099 | $41.6K | — | Jun 7, 2023 | — | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances